HARROW, INC.: Opaleye Management Inc. amends Schedule 13G stake filing

Opaleye Management Inc. amended its Schedule 13G filing for Harrow, Inc., updating its disclosed stake in the pharmaceutical company with the SEC under accession number 0001493152-26-050452. The filing reflects a change in the investment manager's reported position, though the amended document did not immediately specify the revised share count or percentage. Schedule 13G amendments are typically filed when a passive investor's ownership crosses the 5% threshold or moves by more than 5% of the class, making the update a signal of shifting institutional interest in Harrow. Investors will watch for the specific stake size and any further 13G or 13D activity to gauge whether Opaleye is building or trimming its position.